“Ibudilast Ameliorates Acute Pancreatitis through Downregulation of Interleukin-1 Beta and Lipase Enzyme” (2020) Asian Journal of Pharmaceutics (AJP), 14(1). doi:10.22377/ajp.v14i1.3473.